DBS-MS 500 Hematocrit
Dried Blood Spot testing uses dry
spots of blood on a paper card instead of liquid blood/plasma. It is an easy
way of collecting, shipping and storing blood samples.
DBS has several advantages over
collection of liquid blood.
CAMAG DBS-MS 500 HCT enables a
fully automated system capable of barcode based sample ID, automated spraying
of an internal standard to the blood spot, followed by sample extraction. The
extract is guided online to an analytical system of choice (i.e. MS/MS-
MS/LC-MS/PAL-ELISA), and the system is cleaned after each extraction to ensure
zero carryover.
Its applications are enormous,
from newborn screening, dope testing of athletes, drug testing, serological surveys, therapeutic drug
monitoring etc.
Newborn Screening: The traditional punch-and-elute Newborn Screening testing sample
collection method is a very labor-intensive process. Automated DBS-MS systems
attached to Mass spectrometry analyzers, is a faster way to collect samples
where a circular area of the DBS is directly eluted from the filter paper card
without any punching. The advantage of
using this is reduced analysis and labor cost while improving the results.
Fig 1: DBS setup for the
analysis of newborn screening
Dope testing of Athletes: DBS-MS can be used for anti-doping
purposes. It offers a reliable high-throughput analysis with minimum turnaround
time. In addition, with the Hematocrit (HCT) detection module, the results can
be targeted to a hematocrit value. In 2019, the World Anti-Doping Agency (WADA)
announced the development and implementation of DBS for routine analysis for
the 2022 Winter Olympics and Paralympic Games in Beijing. The advantages
included increased sampling intervals at the same time reducing storage and
shipping costs of the samples.
Drug Testing: The use of DBS in drug screening offers an innovative
way to simplify the blood collection process while reducing costs at the same
time. It can combine on-site sampling and highly reliable and efficient drug
testing, by sampling four small blood spots of about 10-20 uL from the
fingertip of the subject and sending the samples to a centralized laboratory,
where testing can be done.
Serological Testing: The formation and reduction of IgG and IgM antibodies against SARS-CoV-2
play an important role in epidemiological studies. Researchers have identified that Dried Blood Spot
testing (DBS)
can be used for serological testing of SARS-CoV-2 antibodies in a simple and
hassle-free manner. The
advantage of using the DBS-MS 500 HCT (Hematocrit) method is that the sampling
numbers for blood based detection of COVID-19 can be increased with accuracy,
as the time of analysis is reduced significantly due to automation. By using
the DBS-MS 500 HCT, the costs associated with sample processing, storage and
shipment can be reduced significantly.
Fig 2: CoVid antibody analysis using DBS-MS 500 HCT for
population screening
DBS-MS as an alternative to conventional blood testing is
a game changer with multiple benefits.
References:
- Figure 1; CAMAG
Application Note on New-born Screening using DBS-MS.
- Figure 2;
CAMAG Application Note on serological testing of SARS-CoV-2 antibodies.
Comments
Post a Comment